Comparison

LY2228820 European Partner

Item no. M2318-5mg
Manufacturer AbMole
CASRN 862507-23-1
Amount 5mg
Category
Type Inhibitors
Specific against other
Purity >99.0%
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Ralimetinib dimesylate; LY2228820 dimesylate; LY2228820 2MsOH
Available
Target Information
p38 MAPK
Molecular Weight
612, 74
Solubility
DMSO 20 mg/mL; Water 83 mg/mL
Bioactivity information
LY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close